Mutational analysis and clinical correlation of metastatic colorectal cancer.
about
Impact of somatic mutations on patterns of metastasis in colorectal cancerRAS and BRAF in metastatic colorectal cancer managementPI3K pathway mutations are associated with longer time to local progression after radioembolization of colorectal liver metastases.DNA methylation epigenotype and clinical features of NRAS-mutation(+) colorectal cancerPredictive model for high-frequency microsatellite instability in colorectal cancer patients over 50 years of age.Current approaches for predicting a lack of response to anti-EGFR therapy in KRAS wild-type patientsCorrelation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancerHigh BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort.LINE-1 hypomethylation in normal colon mucosa is associated with poor survival in Chinese patients with sporadic colon cancer.Impact of RAS and BRAF mutations on carcinoembryonic antigen production and pattern of colorectal metastasesIdentification of T-cell Receptors Targeting KRAS-Mutated Human Tumors.Mutation profiling in chinese patients with metastatic colorectal cancer and its correlation with clinicopathological features and anti-EGFR treatment response.(18)F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status.Review on adjuvant chemotherapy for rectal cancer - why do treatment guidelines differ so much?Pattern and Dynamics of Distant Metastases in Metastatic Colorectal Cancer.Segmental distribution of some common molecular markers for colorectal cancer (CRC): influencing factors and potential implications.Clinical significance of circulating plasma DNA in gastric cancer.mRNA expression profiles in circulating tumor cells of metastatic colorectal cancer patients.Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers.LRF inhibits p53 expression in colon cancer cells via modulating DAP5 activity.Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis.Clinical relevance of alterations in quantity and quality of plasma DNA in colorectal cancer patients: based on the mutation spectra detected in primary tumors.Deficient mismatch repair and RAS mutation in colorectal carcinoma patients: a retrospective study in Eastern China.Mutations of key driver genes in colorectal cancer progression and metastasis.Oncogene mutation profile predicts tumor regression and survival in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and radical surgery.Frequency of NRAS Gene Mutation in Wild Type KRAS and BRAF Colorectal Cancers; a Single Center Study.Predictive and Prognostic Implications of Mutation Profiling and Microsatellite Instability Status in Patients with Metastatic Colorectal Carcinoma.Upregulation of c-mesenchymal epithelial transition expression and RAS mutations are associated with late lung metastasis and poor prognosis in colorectal carcinoma.
P2860
Q26772279-C14EFCF2-96A2-4C29-8289-ED6C248562D5Q28074175-8226CC25-471B-46EA-BC28-3C03F6F22320Q33618754-D6E06958-8F49-4FC6-9C14-318C0E621105Q33679684-DBD44978-E50D-42D6-A5D3-FBAB5D73C873Q33775336-6567A053-C828-4E1B-8E94-4482D7846711Q33861210-1801208C-47DC-4436-852D-07313DDDFE34Q35198335-FA82C60F-8306-468A-8406-71207EF4FAFAQ35677169-455DA380-6A3F-4E2C-AF37-8262E26DFB4AQ36414307-6E95102E-24B5-49CE-B44A-779BFB7D91B0Q36465989-0861E22C-496F-471D-9AB4-FB6CEFD072EEQ36643027-54FAEE50-C9B9-4C8B-940B-A0EFC30EB046Q37317549-C396BC9A-25D6-4E40-BBEF-126524BBB413Q37600941-36E0D780-10E2-483A-A61D-4BC7C7F03717Q38322257-213D40FB-F6BF-4820-9663-30C1D00AD215Q38671275-FB0FE028-8E29-4566-A65B-AF8A57360C8CQ38722180-18885383-46AC-4762-82A7-5B7C129624DDQ40948643-BF74A091-CD7F-4D82-9D59-7D9CBA4C5B1FQ41136311-820C8628-D62F-4296-B9B4-6B5E6A76850DQ46185591-4B26EEBE-8633-4392-8B94-7D2EBEAE84FAQ47889968-42A4E97A-3A80-47AF-914A-A70CE564954AQ48072505-F2F0CD20-7374-4C6C-A1E9-ECD0299BF298Q48292008-93297AAB-5CCD-41F4-809D-3EB551AA3F21Q49307611-5AFC855F-FC67-45CA-B309-030E0D14EDB2Q50097873-CE1E9D20-656B-4F8F-9E49-584F2C5CAAF8Q50549156-83DFEA38-A049-482F-B0D4-77F54F19A742Q54949200-3931300C-0CCD-447F-AC4F-027AAEAB3E5AQ55028937-03C2E663-E336-4D42-8BE8-38B2D57ED875Q55408333-660CCECA-6500-4FFA-9811-1ABD84C5B407
P2860
Mutational analysis and clinical correlation of metastatic colorectal cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mutational analysis and clinical correlation of metastatic colorectal cancer.
@ast
Mutational analysis and clinical correlation of metastatic colorectal cancer.
@en
type
label
Mutational analysis and clinical correlation of metastatic colorectal cancer.
@ast
Mutational analysis and clinical correlation of metastatic colorectal cancer.
@en
prefLabel
Mutational analysis and clinical correlation of metastatic colorectal cancer.
@ast
Mutational analysis and clinical correlation of metastatic colorectal cancer.
@en
P2093
P2860
P356
P1433
P1476
Mutational analysis and clinical correlation of metastatic colorectal cancer.
@en
P2093
Andrea L Russo
Andrew X Zhu
Anthony J Iafrate
Darrell R Borger
David P Ryan
Dora Dias-Santagata
Eunice L Kwak
Jackie Szymonifka
Janet E Murphy
Jason E Faris
P2860
P304
P356
10.1002/CNCR.28599
P407
P577
2014-02-05T00:00:00Z